Cells were treated with gefitinib (5 μM) or BKM120 (500 nM) for 72 hours, and viability was measured by trypan blue staining. Quantification was performed using a one-way analysis of variance (ANOVA) with Tukey’s multiple comparison post-test.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.